2nd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$2,250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement US-Peru Free Trade Agreement Implementation US-Columbia Free Trade Agreement US-Panama Free Trade Agreement (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Israel Patent Issues (no bills) Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation Trans Pacific Partnership (TPP) Negotiations

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
ANTHONY PRINCIPI —

Contacted: Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); Food & Drug Administration (FDA)

Defense DEF

VA Drug Coverage Smoking Cessation Coverage

LobbyistCovered position, as disclosed
LOUIS A LAMARCA —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Health Issues HCR

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
MARIA CINO —
JOHN PAUL HALLIWELL —
BRONWEN KAYE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANGELA WALKER RIEMER —

Contacted: Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 1548 (111th), H.R. 1549 (111th), H.Con.Res. 85 (111th), H.R. 2 (111th), H.R. 3200 (111th), H.R. 3962 (111th), H.R. 15 (111th), H.R. 2400 (111th), H.R. 1427 (111th), H.R. 4489 (111th), S. 4 (111th), S. 301 (111th), S. 45 (111th), H.R. 3590 (111th), S.Con.Res. 13 (111th), H.R. 4213 (111th)

Medicare/Medicaid MMM

Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
ANTHONY PRINCIPI —

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 3675 (111th), H.R. 3200 (111th), H.R. 2502 (111th), H.R. 684 (111th)

Budget/Appropriations BUD

Administration budget proposal, deferral and other international tax issues H.R.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010

LobbyistCovered position, as disclosed
BRONWEN KAYE —
ANTHONY PRINCIPI —

Contacted: Defense, Dept of (DOD); SENATE; State, Dept of (DOS); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3293 (111th)

Consumer Issues/Safety/Products CSP

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANGELA WALKER RIEMER New —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); State, Dept of (DOS); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA)

Bills named: S. 80 (111th), S. 1383 (111th), H.R. 759 (111th), H.R. 573 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 882 (111th), S. 501 (111th), H.R. 1259 (111th)

Copyright/Patent/Trademark CPT

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09

LobbyistCovered position, as disclosed
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Bills named: S. 369 (111th), S. 515 (111th), H.R. 1706 (111th), S. 299 (111th), H.R. 1260 (111th)

Taxation/Internal Revenue Code TAX

Deferral Deferral for active-financing income- extension S. 1203 - R& E Tax Credit Extension and Enhancement H.R. 422 - R&E Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension

LobbyistCovered position, as disclosed
ANTHONY PRINCIPI —

Contacted: Defense, Dept of (DOD); Executive Office of the President (EOP); State, Dept of (DOS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2098 (111th), S. 1203 (111th), H.R. 422 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.